MDCX · Medicus Pharma Ltd. · Financials
Substantial doubt about the company's ability to continue as a going concern.
“This uncertainty, together with the Company's history of losses and its outstanding debt obligations, including debt that will become current by year-end 2026, indicates that substantial doubt exists about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed Nov 6, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| — | -$197.38K | $25.39K | — | |
| $12.16M | $7.72M | $3.53M | $193.58K | |
| $20.17M | $17.92M | $7.65M | $4.54M | |
| $42.33M | $34.36M | $11.18M | $4.73M | |
| -$42.33M | -$34.36M | -$11.18M | -$4.73M | |
| -$1.76M | -$1.09M | $25.39K | -$584.82K | |
| — | $0 | $0 | $0 | |
| -$50.91M | -$47.28M | -$11.16M | -$5.31M | |
| -$58.53K | -$146 | $0 | — | |
| — | -$47.28M | -$11.16M | -$5.31M | |
| -$50.97M | -$47.29M | -$11.16M | — | |
| USD/shares | -$75.96 | -$137.00 | -$58.00 | -$76.50 |
| USD/shares | -$75.96 | -$137.00 | -$58.00 | -$76.50 |
| shares | — | 345.68K | 192.38K | 69.59K |
| shares | — | 345.68K | 192.38K | 69.59K |
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of secured debt | 2026-09-30 | USD 6,000,000 | 10-Q filed 2026-11-06 |
| Noncurrent loans payable | 2026-09-30 | USD 13,145 | 10-Q filed 2026-11-06 |
| Noncurrent secured debt | 2026-09-30 | USD 14,986,161 | 10-Q filed 2026-11-06 |
| Operating lease liabilities | 2026-09-30 | USD 107,926 | 10-Q filed 2026-11-06 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.